167 related articles for article (PubMed ID: 10321809)
1. Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects.
Hampton AL; Nie G; Salamonsen LA
Mol Hum Reprod; 1999 Apr; 5(4):365-71. PubMed ID: 10321809
[TBL] [Abstract][Full Text] [Related]
2. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression.
Schatz F; Papp C; Aigner S; Krikun G; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):188-93. PubMed ID: 8989257
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives.
Vincent AJ; Zhang J; Ostor A; Rogers PA; Affandi B; Kovacs G; Salamonsen LA
Hum Reprod; 2000 Jan; 15(1):123-30. PubMed ID: 10611200
[TBL] [Abstract][Full Text] [Related]
4. Testosterone inhibits matrix metalloproteinase-1 production in human endometrial stromal cells in vitro.
Ishikawa T; Harada T; Kubota T; Aso T
Reproduction; 2007 Jun; 133(6):1233-9. PubMed ID: 17636177
[TBL] [Abstract][Full Text] [Related]
5. Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell.
Wahab M; Taylor AH; Pringle JH; Thompson J; Al-Azzawi F
Mol Hum Reprod; 2006 Mar; 12(3):157-67. PubMed ID: 16556677
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal.
Lockwood CJ; Krikun G; Hausknecht VA; Papp C; Schatz F
Endocrinology; 1998 Nov; 139(11):4607-13. PubMed ID: 9794472
[TBL] [Abstract][Full Text] [Related]
7. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A
Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.
Chegini N; Rhoton-Vlasak A; Williams RS
Fertil Steril; 2003 Sep; 80(3):564-70. PubMed ID: 12969699
[TBL] [Abstract][Full Text] [Related]
11. Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?
Vincent AJ; Zhang J; Ostör A; Rogers PA; Affandi B; Kovacs G; Salamonsen LA
Hum Reprod; 2002 May; 17(5):1189-98. PubMed ID: 11980737
[TBL] [Abstract][Full Text] [Related]
12. Comparison of norethindrone and medroxyprogesterone acetate with natural progesterone and estradiol in stimulating prolactin production from cultured endometrial stromal cells.
Levin JH; Tonetta SA; Lobo RA
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1932-8. PubMed ID: 2147816
[TBL] [Abstract][Full Text] [Related]
13. The effects of progesterone and progestins on endometrial proliferation.
Moyer DL; Felix JC
Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
[TBL] [Abstract][Full Text] [Related]
14. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts.
Singer CF; Marbaix E; Lemoine P; Courtoy PJ; Eeckhout Y
Eur J Biochem; 1999 Jan; 259(1-2):40-5. PubMed ID: 9914473
[TBL] [Abstract][Full Text] [Related]
15. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel.
Skinner JL; Riley SC; Gebbie AE; Glasier AF; Critchley HO
Hum Reprod; 1999 Mar; 14(3):793-9. PubMed ID: 10221716
[TBL] [Abstract][Full Text] [Related]
16. Non-human primate models; artificial menstrual cycles, endometrial matrix metalloproteinases and s.c. endometrial grafts.
Brenner RM; Rudolph L; Matrisian L; Slayden OD
Hum Reprod; 1996 Oct; 11 Suppl 2():150-64. PubMed ID: 8982757
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the potency of orally administered progestins in women.
King RJ; Whitehead MI
Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605
[TBL] [Abstract][Full Text] [Related]
18. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the tissue factor gene by progestins in human endometrial stromal cells.
Krikun G; Schatz F; Mackman N; Guller S; Lockwood CJ
J Clin Endocrinol Metab; 1998 Mar; 83(3):926-30. PubMed ID: 9506750
[TBL] [Abstract][Full Text] [Related]
20. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
